Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Treatment for women news

Show

From To
Starting antiretroviral treatment does not reduce the incidence or prevalence of cervical infection with human papillomavirus

Starting antiretroviral treatment does not reduce the incidence or prevalence of cervical infection with human papillomavirus, US investigators report in the online journal BMC Infectious Diseases. All

Published
18 October 2010
By
Michael Carter
Adherence key to reducing genital HIV levels in women

Sub-optimal adherence to antiretroviral therapy is the single most important factor associated with genital shedding of HIV in women, investigators report in the online edition of the

Published
12 October 2010
By
Michael Carter
Detectable genital HIV shedding associated with cervical infections appears minimal among women taking ART

Results from a small Kenyan study suggest that cervical HIV viral load levels remain low during episodes of cervical infection in HIV-positive women taking antiretroviral therapy (ART). The finding

Published
01 October 2010
By
Kelly Safreed-Harmon
Darunavir/ritonavir as effective in women as men

Darunavir/ritonavir-based antiretroviral therapy is equally effective in treatment-experienced women and men, US investigators report in the Annals of Internal Medicine. However, within four weeks of the study starting,

Published
22 September 2010
By
Michael Carter
High genital HIV levels may persist in women who appear to achieve viral suppression with use of ART

HIV-positive women whose plasma HIV RNA viral loads drop to undetectable levels following initiation of ART still may have intermittent surges in the amount of virus in

Published
06 September 2010
By
Kelly Safreed-Harmon
Nevirapine toxicity in women predicted by liver function, not CD4 count, developing country study reports

Abnormal liver function tests at baseline, not CD4 cell counts over 250 cells/mm³, were predictors for severe liver damage and associated rash researchers among women in Zambia, Thailand

Published
01 September 2010
By
Carole Leach-Lemens
Kesho Bora study reports on effects on maternal health of stopping triple ART after breastfeeding

Stopping triple antiretroviral drug treatment, begun in pregnancy and continued throughout the breast feeding period, was not associated with faster disease progression eighteen months after stopping treatment, researchers

Published
26 August 2010
By
Carole Leach-Lemens
Low birth weight seen in small minority of infants exposed to some antiretroviral drugs

Analyses of 20 years of data from the Antiretroviral Pregnancy Register (APR) shows no risk of birth defects or other defects from antiretroviral use, either in combination or

Published
22 July 2010
By
Carole Leach-Lemens
Meta-analysis suggests efavirenz does not increase risk of birth abnormalities

Treatment with efavirenz during the first three months of pregnancy does not increase the risk of birth abnormalities, according to the results of a systematic

Published
02 June 2010
By
Michael Carter
HIV-positive women in clinical trials: A gap in the facts

Sharon L Walmsley is one of a group of female physicians, experts and patient advocates who together set up Women for Positive Action, an organisation that campaigns

Published
01 June 2010
From
HIV treatment update

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.